Doğan Fidan is currently the Head of Global Strategic Franchise Immunology and Inflammation at Galderma. He has over 20 years of experience in pharma, public agencies & academia. Prior to joining Galderma, he spent 13 years in Sanofi holding senior corporate roles in commercial, market access, and medical affairs organizations. He also spent four years at NICE in the UK, where he acted as a technical analyst in health technology appraisals. He is a Doctor of Medicine (Hacettepe), holds a PhD in Public Health (Dokuz Eylül), MSc in Health Economics (York), and MBA (Warwick). His research interests include strategic drug development and commercialisation, clinical trial methodologies, health technology assessment, economic modelling and quality of life tools.